Post by Genentech
941,518 followers
In multiple sclerosis (MS), immune-driven inflammation plays a central role in how the disease progresses over time. Advancing our understanding of this biology is critical. BTK inhibitors are being studied for their potential to more precisely target this underlying immune activity, with the goal of helping preserve brain function across forms of MS. Learn more about our scientific approach: http://spr.ly/6047B6ApVd
Video Content